{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:22:15Z","timestamp":1737696135440,"version":"3.33.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jfo.2024.104307","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T11:55:48Z","timestamp":1728302148000},"page":"104307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["N\u00e9vrite optique associ\u00e9e aux anticorps anti-glycoprot\u00e9ine de la my\u00e9line oligodendrocytaire postinfection au SARS-CoV-2\u00a0: suivi de quinze\u00a0mois"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-0809","authenticated-orcid":false,"given":"A.","family":"Zahaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lajmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kamoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-4354","authenticated-orcid":false,"given":"S.","family":"Sioud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Abdelkafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-9074","authenticated-orcid":false,"given":"R.","family":"Bourguiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-9273","authenticated-orcid":false,"given":"B.","family":"Ben Achour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2024.104307_bib0070","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00415-020-10300-z","article-title":"Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder","volume":"268","author":"Netravathi","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2024.104307_bib0075","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4103\/ijo.IJO_297_21","article-title":"COVID-19\u00a0and eye: a review of ophthalmic manifestations of COVID-19","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104307_bib0080","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody\u00a0disease","volume":"266","author":"Wynford-Thomas","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2024.104307_bib0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WNO.0000000000001049","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19","volume":"40","author":"Zhou","year":"2020","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2024.104307_bib0090","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2024.104307_bib0095","doi-asserted-by":"crossref","first-page":"577933","DOI":"10.1016\/j.jneuroim.2022.577933","article-title":"Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2\u00a0infection: a case series","volume":"370","author":"Lambe","year":"2022","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jfo.2024.104307_bib0100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2169\/internalmedicine.8709-21","article-title":"SARS-CoV-2-related myelin oligodendrocyte glycoprotein antibody-associated disease: a case report and literature review","volume":"61","author":"Ide","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.jfo.2024.104307_bib0105","doi-asserted-by":"crossref","first-page":"NP87","DOI":"10.1177\/11206721221136319","article-title":"MOG-IgG positive optic neuritis after SARS-CoV-2\u00a0infection","volume":"33","author":"Gilardi","year":"2023","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104307_bib0110","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2\u00a0drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jfo.2024.104307_bib0115","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19\u00a0neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jfo.2024.104307_bib0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50\u00a0patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jfo.2024.104307_bib0125","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1097\/WNO.0000000000001116","article-title":"Alterations in the retinal vascular network and structure in mog antibody-associated disease: an optical coherence tomography angiography study","volume":"41","author":"Yu","year":"2021","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2024.104307_bib0065","doi-asserted-by":"crossref","first-page":"1029124","DOI":"10.3389\/fimmu.2023.1029124","article-title":"Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: an OCT\/OCTA study","volume":"14","author":"Lang","year":"2023","journal-title":"Front Immunol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551224002523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551224002523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T16:46:17Z","timestamp":1737650777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551224002523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0181551224002523"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2024.104307","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u00e9vrite optique associ\u00e9e aux anticorps anti-glycoprot\u00e9ine de la my\u00e9line oligodendrocytaire postinfection au SARS-CoV-2\u00a0: suivi de quinze\u00a0mois","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2024.104307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104307"}}